ABP Pediatric Nephrology flashcards
ABP Pediatric Nephrology · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Minimal change disease
- Most common cause of childhood nephrotic syndrome, especially under age 10; light microscopy is normal, proteinuria is selective, and most children respond to corticosteroids within 4 weeks.
- Post-streptococcal glomerulonephritis
- Follows group A streptococcal pharyngitis or impetigo by 1-3 weeks; presents with hematuria, hypertension, edema, low C3, and elevated ASO; resolves with supportive care and C3 normalizes in 6-8 weeks.
- Hemolytic uremic syndrome
- Triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury, usually from Shiga toxin-producing E. coli O157:H7; treatment is supportive with dialysis, avoiding antibiotics and antimotility drugs.
- Alport syndrome
- X-linked nephritis from COL4A5 mutations; presents with microscopic hematuria, progressive chronic kidney disease, sensorineural hearing loss, and anterior lenticonus; ACE inhibitors slow progression.
- Osmotic demyelination prevention
- Correcting chronic hyponatremia faster than 8-10 mEq/L per 24 hours risks osmotic demyelination; hypertonic saline is reserved for seizures or severe symptoms.
- Proximal renal tubular acidosis
- Type 2 RTA: impaired proximal bicarbonate reabsorption causes bicarbonaturia and hypokalemia; urine pH falls below 5.5 once bicarbonate is depleted; may accompany Fanconi syndrome.
- Anion gap formula
- Anion gap equals sodium minus the sum of chloride and bicarbonate, normal 8-12 mEq/L; with hypoalbuminemia add 2.5 times (4 minus measured albumin) for the corrected value.
- Hyperkalemia emergency treatment
- Give IV calcium gluconate first when ECG changes are present, then insulin with glucose and albuterol to shift potassium intracellularly; remove potassium with binders or dialysis.
- Pediatric hypertension threshold
- Hypertension is systolic or diastolic blood pressure at or above the 95th percentile for age, sex, and height on three occasions; stage 2 is at or above the 99th percentile plus 5 mmHg.
- White coat hypertension
- Elevated office blood pressure with normal readings on 24-hour ambulatory monitoring; identifying it avoids unnecessary medication and further evaluation.
- Coarctation of the aorta
- Presents with upper-extremity hypertension, lower-extremity hypotension, and diminished femoral pulses; associated with bicuspid aortic valve; may cause residual or recurrent hypertension after repair.
- Bilateral renal artery stenosis
- ACE inhibitors and ARBs are contraindicated because they reduce glomerular filtration pressure, causing acute kidney injury and hyperkalemia in this setting.
- KDIGO acute kidney injury criteria
- AKI is a creatinine rise of at least 0.3 mg/dL within 48 hours, at least 1.5 times baseline within 7 days, or urine output below 0.5 mL/kg/h for 6 hours.
- Fractional excretion of sodium
- FENa equals (urine sodium × plasma creatinine) divided by (plasma sodium × urine creatinine) × 100; below 1% suggests prerenal AKI, above 2% suggests intrinsic injury, and diuretics make it unreliable.
- Tumor lysis syndrome
- Hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia from massive cell lysis; treat with aggressive hydration and rasburicase to lower uric acid.
- Continuous renal replacement therapy
- Preferred for hemodynamically unstable children with AKI, severe fluid overload, or need for gradual solute and fluid removal; modalities include CVVH, CVVHD, and CVVHDF.
- CKD GFR staging
- KDIGO stages chronic kidney disease by GFR: G1 at least 90, G2 60-89, G3a 45-59, G3b 30-44, G4 15-29, and G5 below 15 mL/min/1.73 m².
- CKD mineral bone disease
- Phosphate retention and low calcitriol cause hypocalcemia and secondary hyperparathyroidism; treat with dietary phosphate restriction, phosphate binders, and active vitamin D.
- Growth hormone in CKD
- Recombinant human growth hormone at about 0.05 mg/kg/day improves height velocity in children with CKD and growth failure after nutrition, acidosis, and bone disease are optimized.
- CKD anemia management
- Normocytic normochromic anemia results from low erythropoietin; correct iron deficiency first, then use erythropoiesis-stimulating agents targeting hemoglobin around 11-12 g/dL.
- Peritoneal dialysis peritonitis
- Cloudy effluent with abdominal pain and effluent white count above 100 cells/mm³, mostly neutrophils, indicates peritonitis; treat with intraperitoneal vancomycin plus a cephalosporin.
- Dialysis disequilibrium syndrome
- Cerebral edema from rapid urea removal during early dialysis sessions; prevent with shorter, slower first treatments and mannitol; presents with headache, seizures, and altered mental status.
- Arteriovenous fistula maturation
- Arteriovenous fistulas are the preferred hemodialysis access in children over about 20 kg and require 6-8 weeks to mature before first use.
- CVVH versus CVVHD
- CVVH uses convective clearance with replacement fluid, CVVHD uses diffusive clearance with dialysate, and CVVHDF combines both to achieve higher solute clearance.
- Tacrolimus monitoring
- Calcineurin inhibitor that blocks IL-2 transcription and T-cell activation; monitored by trough levels, and causes nephrotoxicity, hyperkalemia, hypomagnesemia, tremor, and hypertension.
- Acute cellular rejection
- Rising creatinine, fever, and graft tenderness weeks to months after transplant; biopsy shows interstitial lymphocytic infiltrate and tubulitis; treated with pulse corticosteroids.
- BK virus nephropathy
- Polyomavirus reactivation causes tubulointerstitial nephritis and graft dysfunction; screen with urine decoy cells and plasma PCR; primary treatment is reduction of immunosuppression.
- Post-transplant lymphoproliferative disorder
- EBV-driven lymphoid proliferation from intensified immunosuppression; presents with lymphadenopathy, fever, or a graft mass; treat by reducing immunosuppression and using rituximab.
- Posterior urethral valves
- Most common lower urinary tract obstruction in boys; bilateral hydronephrosis, thick-walled bladder, and keyhole urethra on imaging; treat with catheter drainage and endoscopic valve ablation.
- Vesicoureteral reflux grading
- Graded I-V by voiding cystourethrogram; grade I involves the ureter only and grade V shows gross dilation and tortuosity; management ranges from observation to antibiotic prophylaxis and surgery.
- Autosomal recessive polycystic kidney disease
- PKHD1 mutations cause enlarged cystic kidneys, congenital hepatic fibrosis, and portal hypertension; severe perinatal disease causes oligohydramnios and Potter sequence.
- Nephrogenic diabetes insipidus
- Renal resistance to vasopressin from AVPR2 or aquaporin-2 mutations; causes polyuria, dilute urine, and hypernatremia; treated with a low-solute diet, thiazides, and amiloride.